Login  |  Logout  |  Register  |  Search PDSA.org  |  Help  |  Contact Us
Education.  Advocacy.  Research.  Support.
Donate to PDSA Connect with PDSA on FacebookFollow PDSA on TwitterPDSA's YouTube ChannelPDSA's LinkedIn Profile


Periodically, PDSA seeks opinions on various aspects of treating and living with ITP. Below are the results from some recent surveys.

What You Said: “The Impact of ITP” Questionnaire Findings

gsk2Thank you to those who shared your ITP experiences through our online survey, and thanks to GlaxoSmithKline for funding and developing the questionnaire.

Download PDF

Non-Traditional Treatments of ITP

In conjunction with James Bussel, MD of the Weill Medical Center of Cornell University, 916 participants answered questions concerning their experience with traditional and non-traditional (complementary) treatments as well as commented on physician communication.

View Results

Health-Related Quality Of Life

A total of 1,002 ITP patients and 1,031 age and gender-matched controls answered questions from three standard quality-of-life questionnaires plus additional questions in a survey funded by Amgen. Selected results were published in three journal articles. Below are links to the abstracts. Contact PDSA for copies of the articles.

  • “Impact of ITP on physician visits and workplace productivity.”

    View Abstract

  • “Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey.”

    View Abstract

  • “Impact of corticosteroid-related symptoms in patients with immune thrombocytopenic purpura: results of a survey of 985 patients.”

    View Abstract